Año: 2022
Journal Impact Factor (JIF): 7.0
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| CHEMISTRY, MEDICINAL | SCIE | 6/60 | Q1 | T1 | D1 |
| FOOD SCIENCE & TECHNOLOGY | SCIE | 13/142 | Q1 | T1 | D1 |
| BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | 46/285 | Q1 | T1 | D2 |
Año: 2022
Journal Citation Indicator (JCI): 1,230
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | 49/315 | Q1 | T1 | D2 | 84,60 |
| CHEMISTRY, MEDICINAL | 13/70 | Q1 | T1 | D2 | 82,14 |
| FOOD SCIENCE & TECHNOLOGY | 24/170 | Q1 | T1 | D2 | 86,18 |
Año:
2022
CiteScore:
8,800
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Biochemistry | 85/428 | Q1 | T1 | D2 |
| Food Science | 41/359 | Q1 | T1 | D2 |
| Physiology | 30/182 | Q1 | T1 | D2 |
| Clinical Biochemistry | 24/113 | Q1 | T1 | D3 |
| Cell Biology | 81/274 | Q2 | T1 | D3 |
| Molecular Biology | 101/380 | Q2 | T1 | D3 |
SJR año:
2022
Factor de Impacto:
1,084
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Food Science | 29/387 | Q1 | T1 | D1 |
| Biochemistry | 105/454 | Q1 | T1 | D3 |
| Clinical Biochemistry | 28/122 | Q1 | T1 | D3 |
| Physiology | 43/198 | Q1 | T1 | D3 |
| Cell Biology | 112/299 | Q2 | T2 | D4 |
| Molecular Biology | 149/432 | Q2 | T2 | D4 |
| Agencia | Código de Proyecto |
|---|---|
| Conselleria de Sanitat Universal i Salut Publica | ACIF/2017/318; ACIF/2018/254; ACIF2019/257; ACIF2019/250 |
| European Union through the Operational Program of the European Regional Development Fund (FEDER) of the Valencian Community 2014-2020 | - |
| FEDER "una manera de hacer Europa" | - |
| INNCON-2020-6-CARVEMO from Agencia Valenciana de Innovacion | - |
| Instituto de Salud Carlos III | PI19/0245; RD16/0011/0004; RD16/0011/0037 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Sánchez-Sánchez, R | Inst Invest Sanitaria La Fe (Spain) |
| 2 | Reinal, I | Inst Invest Sanitaria La Fe (Spain) |
| 3 | Peiró-Molina, E | Inst Invest Sanitaria La Fe (Spain) |
| 4 | Buigues, M | Inst Invest Sanitaria La Fe (Spain) |
| 5 | Tejedor, S | Inst Invest Sanitaria La Fe (Spain) |
| 6 | Hernándiz, A | Inst Invest Sanitaria La Fe (Spain) |
| 7 | Selva, M | Inst Invest Sanitaria La Fe (Spain) |
| 8 | Hervás, D | Universitat Politècnica de València; Inst Invest Sanitaria La Fe (Spain) |
| 9 | Cañada, AJ | Inst Invest Sanitaria La Fe (Spain) |
| 10 | Dorronsoro, A | Consejo Superior de Investigaciones Cientificas (CSIC); Inst Invest Sanitaria La Fe (Spain) |
| 11 | Santaballa, A | Inst Invest Sanitaria La Fe (Spain) |
| 12 | Salvador, C | Inst Invest Sanitaria La Fe (Spain) |
| 13 | Caiment, F | Maastricht University (Netherlands) |
| 14 | Kleinjans, J | Maastricht University (Netherlands) |
| 15 | Martínez-Dolz, L | Instituto de Salud Carlos III; Inst Invest Sanitaria La Fe (Spain) |
| 16 | Moscoso, I | Instituto de Salud Carlos III; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela (Spain) |
| 17 | Lage, R | Instituto de Salud Carlos III; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela (Spain) |
| 18 | González-Juanatey, JR | Instituto de Salud Carlos III; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela (Spain) |
| 19 | Panadero, J | IGenomix (Spain) |
| 20 | Aparicio-Puerta, E | Saarland University (Germany) |
| 21 | Bernad, A | CSIC - Centro Nacional de Biotecnologia (CNB) (Spain) |
| 22 | Instituto de Salud Carlos III; Inst Invest Sanitaria La Fe (Spain) |
